Regional Directors:

Terry Mamounas, MD, MPH, FACS
Medical Director,
Breast Program and Research Activities
Breast Surgical Oncologist
AdventHealth Cancer Institute

Wassim Mchayleh, MD, MBA, FACP
Medical Director, Breast Oncology, Breast Medical Oncologist, AdventHealth Cancer Institute

Date:
March 21, 2025

Time:
12:00PM - Registration

1:00PM - Program Starts

5:30PM - Program Ends

Venue:
AdventHealth Werner Auditorium
601 East Rollins Street, Orlando, Florida, 32803

Parking:
Complimentary Parking at the Alden Parking Garage located on the corner of Rollins Street & Alden Road. Take the garage elevator to the third floor to access the crosswalk. Werner Auditorium is located on the first floor in the main hospital.

Valet Parking Available with Validation provided at registration desk.

Registration Fees: 

Physician: $75

Nurse/Nurse Practitoner/Physician Assistant: $35

Resident/Fellow: $25

Industry: $300

Interested in Sponsorship Opportunites

www.bestofsabcs.com/sponsorship

Location of Venue

This Activity is Supported by an Educational Grant from:
AstraZeneca, Daiichi Sankyo, Exact Sciences, Pfizer, Stemline/Menarini, Puma Biotechnology

Program Overview

Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.

Current Agenda

Time Name Speakers
Friday, March 21, 2025
12:00 PM - 1:00 PMRegistration Opens & Exhibits Open  
1:00 PM - 1:15 PMWelcome/Program Overview/Pre-TestTerry Mamounas, AdventHealth Cancer InstituteTerry Mamounas
1:15 PM - 1:45 PMTriple Negative Early & Metastatic Breast CancerWilliam Gradhishar, Northwestern University Feinberg School of MedicineWilliam Gradhishar
1:45 PM - 2:15 PMHER2 Positive Early & Metastatic Breast CancerAdam Brufsky, University of Pittsburgh Comprehensive Cancer CenterAdam Brufsky
2:15 PM - 2:30 PMSpeaker Panel: Q & A Session  
2:30 PM - 3:15 PMRefreshment Break & Visit with Exhibitors & Supported Symposium  
3:15 PM - 3:45 PMER+ Early & Metastatic Breast CancerWassim Mchayleh, AdventHealth Cancer InstituteWassim Mchayleh
3:45 PM - 4:15 PMLoco-Regional Therapy ManagementTerry Mamounas, AdventHealth Cancer InstituteTerry Mamounas
4:15 PM - 4:45 PMRisk Assessment, Prevention, Lifestyle Interventions, and Supportive CareKate Lathrop, UT Health Science Center at San AntonioKate Lathrop
4:45 PM - 5:15 PMSpeaker Panel: Q & A Session  
5:25 PM - 5:30 PMPost Test & Closing RemarksTerry Mamounas, AdventHealth Cancer InstituteTerry Mamounas

Learning Objectives

After completion of this program, attendees should be able to:

APPLY evidence-based strategies for preventing, detecting, and diagnosing breast cancer in at-risk patients.
 

CONDUCT biomarker and genetic testing in patients with breast cancer using evidence-based principles to identify
actionable mutations and other tumor characteristics that influence treatment approaches.
 

INCORPORATE new results from preclinical research and clinical trials in all aspects of breast cancer care presented during oral,
poster and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice.
 

INTEGRATE new data from clinical trials of novel therapeutics in breast cancer into local treatment patterns
to align current practices with evidence based approaches, overcome resistance mechanisms, and enhance patient outcomes.

DESIGN treatment plans for patients with breast cancer using individualized treatment strategies based
on breast cancer subtype, clinical characteristics, and patient preferences and goals to optimize therapy.

Target Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

Accreditation Statement

The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.

The UT Health Science Center San Antonio has approved this program for AMA PRA Category 1 Credit™.